Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

DBCOND0130161Neoplasms

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma · Advanced Adenocarcinoma of the Stomach, Including Gastroesophageal Junction
Classified under: Neoplasms
Indicated drugs: Ramucirumab

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

6Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account